NHS approves stronger Wegovy dose for 20% weight loss
The NHS has approved a higher 7.2mg dose of weight loss drug Wegovy, shown to help users lose over a fifth of their body weight. Read about the new option for obesity treatment.
Category : Search result: NHS Wegovy
Weight loss jab benefits vanish after stopping treatment
New research reveals weight returns quickly after stopping injections like Wegovy. Experts question NHS cost-effectiveness and highlight cheaper diet alternatives. Read the full analysis.
Weight Loss Jabs: Experts Question Long-Term Value
New research reveals weight returns quickly after stopping injections like Wegovy. Experts warn of cost concerns for the NHS and suggest cheaper alternatives. Read the full analysis.
Weight Loss Jabs May Need Lifelong Use, Study Warns
New research reveals weight lost on injections like Wegovy is regained rapidly after stopping, raising NHS cost concerns. Discover if these treatments offer long-term value.
Study: Stopping 'Skinny Jabs' Reverses Health Benefits
New research shows weight and key health markers like blood pressure and cholesterol rebound after ending GLP-1 drugs, raising questions about long-term use and holistic obesity care.
Study: Weight returns after stopping obesity jabs
A landmark Oxford review reveals weight regain is rapid after stopping GLP-1 drugs like Wegovy, suggesting a need for lifelong treatment. Experts warn of implications for NHS policy and private costs.
Record 7,000 NHS staff sacked in 'zero tolerance' drive
A record 7,000 NHS staff were dismissed last year as Health Secretary Wes Streeting's 'zero tolerance' policy on poor performance takes effect. Explore the data and the debate over NHS performance management.
Outgoing NHS Trust Chief Issues Dire Warning on Service Future
Nick Hulme, departing after 46 years in the NHS, warns the service must improve fast or risk public turning to 'charlatans'. Read his full, frank assessment of the crisis.
NHS Scotland spends £360k on actors amid waiting lists
Scotland's NHS faces backlash for spending £360,000 on professional actors to role-play patients while 850,000 people remain on waiting lists. Critics demand funds be redirected to frontline care.
NHS faces winter crisis as early flu outbreak threatens thousands
The NHS braces for its toughest winter yet as an early flu season collides with ongoing pressures. Health officials warn of potential thousands of fatalities and overwhelming strain on hospital services across the UK.
NHS recruits thousands of Australian healthcare staff
The NHS is launching an unprecedented recruitment drive in Australia to fill critical staffing gaps, offering relocation packages worth thousands amid ongoing healthcare workforce shortages.
Weight Loss Drug Showdown: Novo Nordisk vs Eli Lilly
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
Scottish NHS boards get £135M emergency bailout
NHS Lanarkshire and NHS Ayrshire & Arran receive staggering £135.5 million in emergency funding, raising serious concerns about patient safety and the sustainability of Scotland's healthcare system.
Scotland's NHS overhaul doomed without staffing fix
Medical leaders sound alarm over Scottish Government's latest NHS recovery plan, warning that without tackling the staffing catastrophe, the health service faces irreversible decline. Exclusive analysis reveals why current proposals fall dangerously short
NHS 'Complete Nightmare' as Hospital Capacity Crisis Deepens
Exclusive investigation reveals the shocking state of NHS hospital capacity as patients face unprecedented delays and overcrowding. Discover why experts warn the system is at breaking point.
NHS bosses warn of longer waiting times crisis
Exclusive: NHS leaders deliver sobering reality check to Rachel Reeves as new figures reveal growing treatment delays and funding shortfalls threatening patient care across Britain.
Wegovy's hidden mental benefits revealed
Stanford psychologist reveals how weight-loss drugs like Wegovy create profound mental changes that could revolutionise obesity treatment beyond mere physical transformation.
Scottish NHS Crisis: 'Cradle to Grave' Care Under Threat
Senior medical leaders sound alarm over Scotland's NHS funding crisis, warning the cherished 'cradle to grave' healthcare principle faces collapse without urgent financial intervention.
NHS doctor quits over 'discriminatory' pension scheme
A respected NHS consultant has dramatically resigned after two decades of service, swearing off his pension in protest against what he calls a 'discriminatory' retirement scheme that's pushing experienced medics out of the health service.
NHS waiting lists slashed by 206,000 patients
New figures reveal significant progress in reducing NHS waiting times with 206,000 fewer patients waiting for treatment, marking a major milestone in healthcare recovery.
NHS 10-minute robotic prostate surgery cuts waiting lists
Exclusive: British surgeons pioneer revolutionary robotic prostate procedures that take just 10 minutes, offering new hope for thousands stuck on NHS waiting lists. Discover how this medical breakthrough is transforming cancer care across the UK.
NHS hospitals cut services as winter pressure mounts
Exclusive: NHS leaders warn of service reductions and longer waits as hospitals across England face unprecedented pressure and staffing shortages ahead of winter.
Weight Loss Injections Cut Heart Attack Risk
Groundbreaking research shows popular weight loss medications like Wegovy and Ozempic dramatically reduce cardiovascular events, offering dual protection for patients.
Academics Urge Lower BMI for Wegovy Access
University College London researchers call for expanding Wegovy access after revealing compelling new evidence that could change NHS obesity treatment guidelines.
Weight loss jabs boost heart health, study finds
Groundbreaking research shows popular weight loss injections like Wegovy and Ozempic significantly reduce cardiovascular risks alongside promoting weight loss, offering new hope for millions.
Weight loss jabs slash heart risk in UK study
Groundbreaking research reveals popular weight loss injections Wegovy and Ozempic significantly reduce heart attack and stroke risks, offering dual benefits for millions struggling with obesity.
Boots withdraws 'fat jab' weight loss injection service
High street pharmacy chain Boots has suspended its popular 'fat jab' weight loss injection service following overwhelming demand and supply shortages, leaving thousands of customers seeking alternatives.
NHS Bureaucracy Exposed: Managers Outnumber Frontline Staff
An NHS doctor's viral revelation exposes staggering bureaucracy as managers outnumber frontline staff, sparking outrage over wasted resources and patient care neglect.
NHS staff fury over parking charge increases
NHS workers across Britain are expressing outrage as hospital trusts implement controversial parking fee increases, adding financial pressure to healthcare heroes already struggling with cost-of-living crisis.
Ozempic & Wegovy Cause Dangerous Scan Complications
Groundbreaking research reveals popular weight-loss drugs Ozempic and Wegovy are causing dangerous stomach complications during medical scans, prompting urgent NHS warnings.
Page 1 of 4